However, given its prominent pro-tumorigenic role in GBM, there are ongoing efforts to refine the therapeutic targeting of TGFβ signaling in GBM [20] which may also be applied to canine high-grade glioma. This evidence concerns the gene TGFB1 and central nervous system cancer.